Novavax COVID vaccine highly effective against severe Covid: company

Novavax COVID vaccine highly effective against severe Covid: company

US biotech firm Novavax’s COVID-19 vaccine was shown to be 100 percent protective against severe cases of the disease, including hospitalization and death, the company said Thursday following trials.

Comments are closed.

‘I’ve aged 30 years’: long COVID patients battle acute symptoms
12 March 2021
Italy braces for widespread COVID closures
12 March 2021